Evidence map›Paper›PMID 40418427›Full record

ArticleUpdates in surgery2025

At the earliest: a Hub and Spoke referral and referral-back pilot project increases access to liver transplantation and ensures good long-term care.

Cecilia Pravadelli, Alberto Ferrarese, Luisa Moser, Francesco Paolo Russo, Giacomo Germani, Marco Senzolo, Martina Gambato, Alberto Zanetto, Sara Battistella, Elisa Menotti and 10 more

Abstract read
In one paragraph

Article in Updates in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Cecilia Pravadelli *Gastroenterology, Trento Hospital, Trento, Italy.
Alberto Ferrarese *Multivisceral Transplant Unit, Gastroenterology, Padua University Hospital, Via Giustiniani 2, 35122, Padua, Italy.ORCID http://orcid.org/0000-0002-3248-2038
Luisa MoserGastroenterology, Trento Hospital, Trento, Italy.
Francesco Paolo RussoMultivisceral Transplant Unit, Gastroenterology, Padua University Hospital, Via Giustiniani 2, 35122, Padua, Italy.
Giacomo GermaniMultivisceral Transplant Unit, Gastroenterology, Padua University Hospital, Via Giustiniani 2, 35122, Padua, Italy.
Marco SenzoloMultivisceral Transplant Unit, Gastroenterology, Padua University Hospital, Via Giustiniani 2, 35122, Padua, Italy.
Martina GambatoMultivisceral Transplant Unit, Gastroenterology, Padua University Hospital, Via Giustiniani 2, 35122, Padua, Italy.
Alberto ZanettoMultivisceral Transplant Unit, Gastroenterology, Padua University Hospital, Via Giustiniani 2, 35122, Padua, Italy.
Sara BattistellaMultivisceral Transplant Unit, Gastroenterology, Padua University Hospital, Via Giustiniani 2, 35122, Padua, Italy.
Elisa MenottiGastroenterology, Trento Hospital, Trento, Italy.
Flora AgugiaroGastroenterology, Trento Hospital, Trento, Italy.
Giovanni VettoriGastroenterology, Trento Hospital, Trento, Italy.
Giovanni de PretisGastroenterology, Trento Hospital, Trento, Italy.
Pamela BallottaMultivisceral Transplant Unit, Gastroenterology, Padua University Hospital, Via Giustiniani 2, 35122, Padua, Italy.
Ivana MaioliGastroenterology, Trento Hospital, Trento, Italy.
Armando GabbrielliGastroenterology, Trento Hospital, Trento, Italy.
Lucia PilatiIntensive Care Unit, Trento Hospital, Trento, Italy.
Tiziano MartelloMedical Management Unit, Padua University Hospital, Padua, Italy.
Umberto CilloDepartment of Surgery, Oncology, Gastroenterology, Padua University Hospital, Via Giustiniani 2, 35122, Padua, Italy.
Patrizia BurraMultivisceral Transplant Unit, Gastroenterology, Padua University Hospital, Via Giustiniani 2, 35122, Padua, Italy. burra@unipd.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver transplantation (LT) represents an effective therapeutic option for patients with end-stage liver disease and hepatocellular carcinoma. However, barriers to access LT programs still exist for many patients, including distance from transplant centers and delays in referral. Furthermore, long-term care is required also in stable LT recipients. This pilot study aims to evaluate the characteristics and outcomes of patients with end-stage liver disease referred to Padua University Hospital following the implementation of a structured referral program with Trento Hospital. Furthermore, the study assesses the outcomes of LT recipients who were referred back and continued follow-up care at the Spoke Center. After an internal work reorganization at the Spoke Center to improve care for patients with liver disease, we designed this prospective pilot study based on a structured referral and referral-back program for managing patients before and after LT. Accordingly, all inpatients potentially eligible for LT were transferred from the Gastroenterology Unit at Trento Hospital to the Multivisceral Transplant Unit at Padua University Hospital between 2020-2023. Similarly, stable LT recipients were referred back to the Spoke Center for management of long-term follow-up. During the study period, 27 adult inpatients (59% male; median age 50 [42-51] years) deemed eligible for LT were consecutively referred from Trento to Padua. The median [IQR] MELD score at the time of referral was 26 [23-30], and the length of stay at the LT Center was 21 [18-23] days. At the end of follow-up, 6 (22%) patients underwent LT, while the transplant-free survival rate was 37%. During the same period, 27 stable adult LT recipients (55% male; median age at referral back 56 years; median time since LT 9 years) living near Trento were referred back to the Spoke Center. During the follow-up, n.19 (70%) patients experienced at least one medical complication (40% liver-related), the majority of these being managed at the Spoke Center. LT recipient satisfaction of this way of care Center was high. A structured Hub and Spoke collaboration increase access to LT, making it more equitable, and improves the management of stable LT recipients closer to home.

Indexed as

End Stage Liver DiseaseHealth Services AccessibilityLiver TransplantationLong-Term CareReferral and ConsultationAdultFemaleHumansMaleMiddle AgedPilot ProjectsProspective StudiesTime FactorsAcute-on-chronic liver failureCirrhosisQuality of life

Identifiers

PMID40418427
PMCPMC12420682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.